Gao, Wei, Zhang, Chunming, Shi, Yong, Yang, Dongli, Zhang, Ruiping, Li, Zhenyu, Cui, Jiajia, Zhang, Yuliang, Niu, Min, Li, Jun, Wu, Zhongqiang, Guo, Huina, Li, Wenqi, Xiang, Caixia, Wang, Juan, Hou, Juan, Zhang, Lu, Thorne, Rick F., Cui, Yongping, Wu, Yongyan, Wen, Shuxin, Wang, Binquan, Li, Huizheng, Sang, Jiangwei, Zhao, Qinli, Bo, Yunfeng, Luo, Hongjie, Zheng, Xiwang, Lu, Yan. Cell Press; 2019. Promoter methylation-regulated miR-145-5p inhibits laryngeal squamous cell carcinoma progression by targeting FSCN1.

Gao, Wei, Zhang, Yuliang, Lu, Yan, Yang, Dongli, Guo, Yujia, Guo, Huina, Li, Huizheng, Zhang, Yu, Yang, Tao, Li, Li, Zhang, Linshi, Hou, Rui, Luo, Hongjie, Wen, Shuxin, An, C., Ma, T., Jin, Lei, Xu, W., Wu, Y., Niu, Min, Zheng, Xiwang, Hu, Wanglai, Cui, Jiajia, Xue, Xuting, Bo, Yunfeng, Dai, Fengsheng. Nature Publishing Group; 2020. Targeting SKA3 suppresses the proliferation and chemoresistance of laryngeal squamous cell carcinoma via impairing PLK1-AKT axis-mediated glycolysis.